The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.
Indolocarbazole natural products: occurrence, biosynthesis, and biological activity
Open accessAbstract
The indolocarbazole family of natural products, including the biosynthetically related bisindolylmaleimides, is reviewed (with 316 references cited). The isolation of indolocarbazoles from natural sources and the biosynthesis of this class of compounds are thoroughly reviewed, including recent developments in molecular genetics, enzymology and metabolic engineering. The biological activities and underlying modes of action displayed by natural and synthetic indolocarbazoles is also presented, with an emphasis on the development of analogs that have entered clinical trials for its future use against cancer or other diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Specificity and mechanism of action of some commonly used protein kinase inhibitors
DAVIES, S. P., REDDY, H., CAIVANO, M., & COHEN, P. (2000) · Biochemical Journal · doi:10.1042/bj3510095 · Cited by 3,132
DNA Topoisomerases: Structure, Function, and Mechanism
Champoux, J. J. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.369 · Cited by 2,743
The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C
Toullec, D., Pianetti, P., Coste, H., Bellevergue, P., Grand-Perret, T., Ajakane, M., Baudet, V., Boissin, P., Boursier, E., & Loriolle, F. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98476-0 · Cited by 2,456
Staurosporine, a potent inhibitor of phospholipidCa++dependent protein kinase
Tamaoki, T., Nomoto, H., Takahashi, I., Kato, Y., Morimoto, M., & Tomita, F. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(86)90008-2 · Cited by 2,452
Protein kinases — the major drug targets of the twenty-first century?
Cohen, P. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd773 · Cited by 2,186
Isolation and Synthesis of Biologically Active Carbazole Alkaloids
Knölker, H., & Reddy, K. R. (2002) · Chemical Reviews · doi:10.1021/cr020059j · Cited by 1,416
Protein Kinase Inhibitors: Insights into Drug Design from Structure
Noble, M. E. M., Endicott, J. A., & Johnson, L. N. (2004) · Science · doi:10.1126/science.1095920 · Cited by 1,198
Walker, E. H., Pacold, M. E., Perisic, O., Stephens, L., Hawkins, P. T., Wymann, M. P., & Williams, R. L. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00089-4 · Cited by 1,197
Natural products to drugs: natural product-derived compounds in clinical trials
Butler, M. S. (2008) · Natural Product Reports · doi:10.1039/b514294f · Cited by 1,075
AH RECEPTOR SIGNALING PATHWAYS
Schmidt, J. V., & Bradfield, C. A. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.55 · Cited by 899
Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases
Rüegg, U. T., & Gillian, B. (1989) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(89)90263-0 · Cited by 897
Bacterial Topoisomerase Inhibitors: Quinolone and Pyridone Antibacterial Agents
Mitscher, L. A. (2005) · Chemical Reviews · doi:10.1021/cr030101q · Cited by 781
Protein phosphorylation in signaling – 50 years and counting
Pawson, T., & Scott, J. D. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.04.013 · Cited by 694
OMURA, S., IWAI, Y., HIRANO, A., NAKAGAWA, A., AWAYA, J., TSUCHIYA, H., TAKAHASHI, Y., & ASUMA, R. (1977) · The Journal of Antibiotics · doi:10.7164/antibiotics.30.275 · Cited by 674
Stone, R. M., DeAngelo, D. J., Klimek, V., Galinsky, I., Estey, E., Nimer, S. D., Grandin, W., Lebwohl, D., Wang, Y., Cohen, P., et al. (2005) · Blood · doi:10.1182/blood-2004-03-0891 · Cited by 657
Smith, B. D., Levis, M., Beran, M., Giles, F., Kantarjian, H., Berg, K., Murphy, K. M., Dauses, T., Allebach, J., & Small, D. (2004) · Blood · doi:10.1182/blood-2003-11-3775 · Cited by 632
Weisberg, E., Boulton, C., Kelly, L. M., Manley, P., Fabbro, D., Meyer, T., Gilliland, D. G., & Griffin, J. D. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00069-7 · Cited by 599
Bjeldanes, L. F., Kim, J. Y., Grose, K. R., Bartholomew, J. C., & Bradfield, C. A. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.21.9543 · Cited by 588
Staker, B. L., Feese, M. D., Cushman, M., Pommier, Y., Zembower, D., Stewart, L., & Burgin, A. B. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049146p · Cited by 546
Simple indole alkaloids and those with a nonrearranged monoterpenoid unit
Higuchi, K., & Kawasaki, T. (2007) · Natural Product Reports · doi:10.1039/b516351j · Cited by 510
Natural products to drugs: natural product derived compounds in clinical trials
Butler, M. S. (2005) · Natural Product Reports · doi:10.1039/b402985m · Cited by 491
Simple indole alkaloids and those with a nonrearranged monoterpenoid unit
Kawasaki, T., & Higuchi, K. (2005) · Natural Product Reports · doi:10.1039/b502162f · Cited by 395
G2 checkpoint abrogators as anticancer drugs
Kawabe, T. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.513.3.4 · Cited by 377
Jirousek, M. R., Gillig, J. R., Gonzalez, C. M., Heath, W. F., McDonald, J. H., Neel, D. A., Rito, C. J., Singh, U., Stramm, L. E., Melikian-Badalian, A., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950588y · Cited by 339
K-252a: a specific inhibitor of the action of nerve growth factor on PC 12 cells
Koizumi, S., Contreras, M., Matsuda, Y., Hama, T., Lazarovici, P., & Guroff, G. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-02-00715.1988 · Cited by 317
The Effect of Ruboxistaurin on Nephropathy in Type 2 Diabetes
Tuttle, K. R., Bakris, G. L., Toto, R. D., McGill, J. B., Hu, K., & Anderson, P. W. (2005) · Diabetes Care · doi:10.2337/diacare.28.11.2686 · Cited by 300
Studies in Natural Product Chemistry
(2023) · Studies in Natural Products Chemistry · doi:10.1016/c2021-0-00193-0 · Cited by 286
(2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1832124100 · Cited by 283
Impact of Violacein-Producing Bacteria on Survival and Feeding of Bacterivorous Nanoflagellates
Matz, C., Deines, P., Boenigk, J., Arndt, H., Eberl, L., Kjelleberg, S., & Jürgens, K. (2004) · Applied and Environmental Microbiology · doi:10.1128/aem.70.3.1593-1599.2004 · Cited by 273
Chromobacterium violaceum: A Review of Pharmacological and Industiral Perspectives
Durán, N., & Menck, C. F. M. (2001) · Critical Reviews in Microbiology · doi:10.1080/20014091096747 · Cited by 273
PKC412--a protein kinase inhibitor with a broad therapeutic potential.
Fabbro, D., Ruetz, S., Bodis, S. B., Pruschy, M. N., Csermak, K., Man, A., Campochiaro, P. A., Wood, J. M., O'Reilly, T., & Meyer, T. (2000) · PubMed · Cited by 271
Lawrie, A. M., Noble, M. E. M., Tunnah, P., Brown, N. R., Johnson, L. N., & Endicott, J. A. (1997) · Nature Structural Biology · doi:10.1038/nsb1097-796 · Cited by 268
Yeh, E., Garneau‐Tsodikova, S., & Walsh, C. T. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500755102 · Cited by 265
Zhu, X., Kim, J. L., Newcomb, J. R., Rose, P. E., Stover, D. R., Toledo, L. M., Zhao, H., & Morgenstern, K. A. (1999) · Structure · doi:10.1016/s0969-2126(99)80086-0 · Cited by 254
Production and biological activity of rebeccamycin, a novel antitumor agent.
BUSH, J. A., LONG, B. H., CATINO, J. J., & BRADNER, W. T. (1987) · The Journal of Antibiotics · doi:10.7164/antibiotics.40.668 · Cited by 252
Combinatorial biosynthesis of antitumor indolocarbazole compounds
Sánchez, C., Zhu, L., Braña, A. F., Salas, A. P., Rohr, J., Méndez, C., & Salas, J. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407809102 · Cited by 244
Self-citationJackson, J. R., Gilmartin, A. G., Imburgia, C. S., Winkler, J. D., Marshall, L. A., & Roshak, A. (2000) · PubMed · Cited by 229
Drug discovery from natural products
Gullo, V. P., McAlpine, J., Lam, K. S., Baker, D., & Petersen, F. (2006) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-006-0107-2 · Cited by 222
The Biosynthetic Gene Cluster for the Antitumor Rebeccamycin
Sánchez, C., Butovich, I. A., Braña, A. F., Rohr, J., Méndez, C., & Salas, J. A. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00126-6 · Cited by 218
Self-citationStaurosporine, a Potentially Important Gift from a Microorganism.
OMURA, S., SASAKI, Y., IWAI, Y., & TAKESHIMA, H. (1995) · The Journal of Antibiotics · doi:10.7164/antibiotics.48.535 · Cited by 216
Cloning and Heterologous Expression of a Natural Product Biosynthetic Gene Cluster from eDNA
Brady, S. F., Chao, C. J., Handelsman, J., & Clardy, J. (2001) · Organic Letters · doi:10.1021/ol015949k · Cited by 215
Structural Basis for Chk1 Inhibition by UCN-01
Zhao, B., Bower, M. J., McDevitt, P. J., Zhao, H., Davis, S. T., Johanson, K. O., Green, S. M., Concha, N. O., & Zhou, B.-B. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201233200 · Cited by 206
Alessi, D. R. (1997) · FEBS Letters · doi:10.1016/s0014-5793(96)01510-4 · Cited by 200
Pim-1 Ligand-bound Structures Reveal the Mechanism of Serine/Threonine Kinase Inhibition by LY294002
Jacobs, M. D., Black, J., Futer, O., Swenson, L., Hare, B., Fleming, M., & Saxena, K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413155200 · Cited by 192
UCN-01, a selective inhibitor of protein kinase C from Streptomyces.
TAKAHASHI, I., KOBAYASHI, E., ASANO, K., YOSHIDA, M., & NAKANO, H. (1987) · The Journal of Antibiotics · doi:10.7164/antibiotics.40.1782 · Cited by 186
Topoisomerase I inhibitors: selectivity and cellular resistance
Pommier, Y., Pourquier, P., Urasaki, Y., Wu, J., & Laco, G. S. (1999) · Drug Resistance Updates · doi:10.1054/drup.1999.0102 · Cited by 182
Vinik, A. I., Bril, V., Kempler, P., Litchy, W. J., Tesfaye, S., Price, K. L., & Bastyr, E. J. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.08.001 · Cited by 171
Crystal structure of the Jak3 kinase domain in complex with a staurosporine analog
Boggon, T. J., Li, Y., Manley, P. W., & Eck, M. J. (2005) · Blood · doi:10.1182/blood-2005-02-0707 · Cited by 170
Marchand, C., Antony, S., Kohn, K. W., Cushman, M., Ioanoviciu, A., Staker, B. L., Burgin, A. B., Stewart, L., & Pommier, Y. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0456 · Cited by 167
Kodach, L. L., Bos, C. L., Durán, N., Peppelenbosch, M. P., Ferreira, C. V., & Hardwick, J. C. H. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi307 · Cited by 160
Tjipanazoles, new antifungal agents from the blue-green alga Tolypothrix tjipanasensis
Bonjouklian, R., Smitka, T. A., Doolin, L. E., Molloy, R. M., Debono, M., Shaffer, S. A., Moore, R. E., Stewart, J. B., & Patterson, G. M. L. (1991) · Tetrahedron · doi:10.1016/s0040-4020(01)81932-3 · Cited by 158
TAKAHASHI, I., Saitoh, Y., Yoshida, M., Sano, H., Nakano, H., Morimoto, M., & Tamaoki, T. (1989) · The Journal of Antibiotics · doi:10.7164/antibiotics.42.571 · Cited by 158
Bullock, A. N., Debreczeni, J. E., Fedorov, O., Nelson, A. S., Marsden, B. D., & Knapp, S. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0504858 · Cited by 157
Schiering, N., Knapp, S., Marconi, M., Flocco, M. M., Cui, J., Perego, R., Rusconi, L., & Cristiani, C. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1734128100 · Cited by 156
Aiello, L. P., Clermont, A. C., Arora, V. M., Davis, M. D., Sheetz, M. J., & Bursell, S. (2005) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-0757 · Cited by 153
Prade, L., Engh, R. A., Girod, A., Kinzel, V., Huber, R., & Bossemeyer, D. (1997) · Structure · doi:10.1016/s0969-2126(97)00310-9 · Cited by 150
Catalytic Domain Crystal Structure of Protein Kinase C-θ (PKCθ)
Xu, Z., Chaudhary, D., Olland, S., Wolfrom, S., Czerwiński, R., Malakian, K., Lin, L., Stahl, M., Joseph‐McCarthy, D., Benander, C., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409216200 · Cited by 147
Yamashita, Y., Fujii, N., Murakata, C., Ashizawa, T., Okabe, M., & Nakano, H. (1992) · Biochemistry · doi:10.1021/bi00163a015 · Cited by 145
Reduction of Diabetic Macular Edema by Oral Administration of the Kinase Inhibitor PKC412
Campochiaro, P. A. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-0955 · Cited by 144
Lamers, M. B. A. C., Antson, A. A., Hubbard, R. E., Scott, R. K., & Williams, D. H. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2369 · Cited by 144
August, P. R., Grossman, T. H., Minor, C., Draper, M. P., MacNeil, I. A., Pemberton, J., Call, K. M., Holt, D., & Osburne, M. S. (2000) · PubMed · Cited by 143
Link, J. T., Raghavan, S., Gallant, M., Danishefsky, S. J., Chou, T., & Ballas, L. M. (1996) · Journal of the American Chemical Society · doi:10.1021/ja952907g · Cited by 138
Qatsha, K. A., Rudolph, C., Marmé, D., Schächtele, C., & May, W. S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.10.4674 · Cited by 136
Yeh, E., Cole, L. J., Barr, E. W., Bollinger, J. M., Jr., Ballou, D. P., & Walsh, C. T. (2006) · Biochemistry · doi:10.1021/bi060607d · Cited by 135
Non-Camptothecin DNA Topoisomerase I Inhibitors in Cancer Therapy
Meng, L., Zhi-yong, L., & Pommier, Y. G. (2003) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026033452546 · Cited by 132
Onaka, H., TANIFGUCHI, S.-I., Igarashi, Y., & FURUMAI, T. (2002) · The Journal of Antibiotics · doi:10.7164/antibiotics.55.1063 · Cited by 131
Pilch, B., Allemand, E., Facompré, M., et al. (2001) · PubMed · Cited by 130
Diversity of DNA topoisomerases I and inhibitors
Pommier, Y. G. (1998) · Biochimie · doi:10.1016/s0300-9084(98)80008-4 · Cited by 124
Salas, A. P., Zhu, L., Sánchez, C., Braña, A. F., Rohr, J., Méndez, C., & Salas, J. A. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04777.x · Cited by 122
Self-citationSenderowicz, A. M. (2002) · The Oncologist · doi:10.1634/theoncologist.7-suppl_3-12 · Cited by 119
Komander, D., Kular, G. S., Jennifer, B. A. I. N., Elliott, M., Alessi, D. R., & van Aalten, D. M. F. (2003) · Biochemical Journal · doi:10.1042/bj20031119 · Cited by 117
Onaka, H., TANIGUCHI, S.-I., Igarashi, Y., & FURUMAI, T. (2003) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.67.127 · Cited by 115
Review of UCN‐01 Development: A Lesson in the Importance of Clinical Pharmacology
Fuse, E., Kuwabara, T., Sparreboom, A., Sausville, E. A., & Figg, W. D. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270005274549 · Cited by 113
Hashimoto, S. (1988) · The Journal of Cell Biology · doi:10.1083/jcb.107.4.1531 · Cited by 112
Nishizawa, T., Aldrich, C. C., & Sherman, D. H. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.6.2084-2092.2005 · Cited by 107
TAKAHASHI, I., Asano, K., Kawamoto, I., Tamaoki, T., & Nakano, H. (1989) · The Journal of Antibiotics · doi:10.7164/antibiotics.42.564 · Cited by 107
Brehmer, D., Godl, K., Zech, B., Wissing, J. B., & Daub, H. (2004) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m300139-mcp200 · Cited by 106
Cytotoxic, antiviral indolocarbazoles from a blue-green alga belonging to the nostocaceae.
Knübel, G., Larsen, L. K., Moore, R. E., Levine, I. A., & Patterson, G. M. L. (1990) · The Journal of Antibiotics · doi:10.7164/antibiotics.43.1236 · Cited by 104
Brown, P. A., Levis, M. J., McIntyre, E., Griesemer, M., & Small, D. (2006) · Leukemia · doi:10.1038/sj.leu.2404277 · Cited by 103
Pommier, Y. G. (2004) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1568011043352777 · Cited by 102
Results from phase II trial of enzastaurin (LY317615) in patients with recurrent high grade gliomas
Fine, H. A., Kim, L., Royce, C., Draper, D., Haggarty, I., Ellinzano, H., Albert, P. S., Kinney, P., Musib, L. C., & Thornton, D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.16_suppl.1504 · Cited by 96
Strock, C. J., Park, J., Rosen, M. A., Dionne, C. A., Ruggeri, B., Jones‐Bolin, S., Denmeade, S. R., Ball, D. W., & Nelkin, B. D. (2003) · PubMed · Cited by 94
Recent Developments of Rebeccamycin Analogues as Topoisomerase I Inhibitors and Antitumor Agents.
Prudhomme, M. (2000) · Current Medicinal Chemistry · doi:10.2174/0929867003374138 · Cited by 94
Mixed lineage kinase activity of indolocarbazole analogues
Murakata, C., Kaneko, M., Gessner, G. W., Angeles, T. S., Ator, M. A., O’Kane, T. M., McKenna, B. A., Thomas, B. A., Mathiasen, J. R., Saporito, M. S., et al. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(01)00690-4 · Cited by 93
Howard‐Jones, A. R., & Walsh, C. T. (2005) · Biochemistry · doi:10.1021/bi051706e · Cited by 93
Acyclic N-(azacycloalkyl)bisindolylmaleimides: isozyme selective inhibitors of PKCβ
Faul, M. M., Gillig, J. R., Jirousek, M. R., Ballas, L. M., Schotten, T., Kahl, A., & Mohr, M. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00286-5 · Cited by 93
Chen, P.-W., & Kroog, G. S. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.001206 · Cited by 91
Querfeld, C., Rizvi, M. A., Kuzel, T. M., Guitart, J., RADEMAKER, A. W., Sabharwal, S. S., Krett, N. L., & Rosen, S. T. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700322 · Cited by 89
Milanesi, L., Petrillo, M., Sepe, L., et al. (2005) · BMC Bioinformatics · doi:10.1186/1471-2105-6-s4-s20 · Cited by 86
Kuo, G., Prouty, C. P., DeAngelis, A., Shen, L., O’Neill, D. J., Shah, C. R., Connolly, P. J., Murray, W. V., Conway, B. R., Cheung, P., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030115o · Cited by 83
New Tryptophan Metabolites from Cultures of the Lipophilic Yeast Malassezia furfur
Irlinger, B., Bartsch, A., Krämer, H., Mayser, P. A., & Steglich, W. (2005) · Helvetica Chimica Acta · doi:10.1002/hlca.200590118 · Cited by 82
Interactions of LY333531 and Other Bisindolyl Maleimide Inhibitors with PDK1
Komander, D., Kular, G. S., Schüttelkopf, A. W., Deák, M., Prakash, K. R. C., Bain, J., Elliott, M., Garrido-Franco, M., Kozikowski, A. P., Alessi, D. R., et al. (2004) · Structure · doi:10.1016/j.str.2004.01.005 · Cited by 79
Akinaga, S., Sugiyama, K., & Akiyama, T. (2000) · PubMed · Cited by 78
Soret, J., Gabut, M., Dupon, C., Kohlhagen, G., Stévenin, J., Pommier, Y., & Tazi, J. (2003) · PubMed · Cited by 77
Unusual Sulfamate Indoles and a Novel Indolo[3,2-a]carbazole from Ancorina sp.1
Meragelman, K. M., West, L. M., Northcote, P. T., Pannell, L. K., McKee, T. C., & Boyd, M. R. (2002) · The Journal of Organic Chemistry · doi:10.1021/jo020120k · Cited by 74
Gao, Q., Zhang, C., Blanchard, S., & Thorson, J. S. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.05.009 · Cited by 69
11-Hydroxystaurosporine: a highly cytotoxic, powerful protein kinase C inhibitor from a tunicate
Kinnel, R. B., & Scheuer, P. J. (1992) · The Journal of Organic Chemistry · doi:10.1021/jo00049a049 · Cited by 68
Wright, A. D., Papendorf, O., & König, G. M. (2005) · Journal of Natural Products · doi:10.1021/np049640w · Cited by 67
Johnson, L. N., Moliner, E. D., Brown, N. R., Song, H., Barford, D., Endicott, J., & Noble, M. E. M. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00181-x · Cited by 66
The Three-dimensional Structure of the ZAP-70 Kinase Domain in Complex with Staurosporine
Jin, L., Pluskey, S., Petrella, E. C., Cantin, S. M., Gorga, J. C., Rynkiewicz, M. J., Pandey, P., Strickler, J. E., Babine, R. E., Weaver, D. T., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407096200 · Cited by 66
Yoshinari, T., Matsumoto, M., Arakawa, H., Okada, H., Noguchi, K., Suda, H., Okura, A., & Nishimura, S. (1995) · PubMed · Cited by 66
Toledo, L. M., & Lydon, N. (1997) · Structure · doi:10.1016/s0969-2126(97)00304-3 · Cited by 65
Staurosporine-induced neurite outgrowth in PC12 cells is independent of protein kinase C inhibition.
Rasouly, D., Rahamim, E., Lester, D. S., et al. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08857-1 · Cited by 64
Staurosporine aglycone (K252-c) and arcyriaflavin A from the marine ascidian,Eudistoma sp
Horton, P. A., Longley, R. E., McConnell, O. J., et al. (1994) · Cellular and Molecular Life Sciences · doi:10.1007/bf01956468 · Cited by 63
Proksch, P., Ebel, R., Edrada‐Ebel, R., Schupp, P. J., Lin, W., Sudarsono, S., Wray, V., & Steube, K. G. (2003) · Pure and Applied Chemistry · doi:10.1351/pac200375020343 · Cited by 62
Protein Kinase C Effectors Bind to Multidrug ABC Transporters and Inhibit Their Activity
Conseil, G., Pérez-Victoria, J. M., Jault, J., Gamarro, F., Goffeau, A., Hofmann, J., & Pietro, A. D. (2001) · Biochemistry · doi:10.1021/bi002453m · Cited by 60
Joy, S. V., Scates, A. C., Bearelly, S., Dar, M. S., Taulien, C. A., Goebel, J. A., & Cooney, M. J. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1e572 · Cited by 60
Arakawa, H., Iguchi, T., Morita, M., Yoshinari, T., KOJIRI, K., Suda, H., Okura, A., & Nishimura, S. (1995) · PubMed · Cited by 60
The Biosynthetic Origins of Rebeccamycin
Pearce, C. J., Doyle, T. W., Forenza, S., et al. (1988) · Journal of Natural Products · doi:10.1021/np50059a020 · Cited by 57
KOJIRI, K., KONDO, H., Yoshinari, T., Arakawa, H., Nakajima, S., SATOH, F., KAWAMURA, K., Okura, A., Suda, H., & OKANISHI, M. (1991) · The Journal of Antibiotics · doi:10.7164/antibiotics.44.723 · Cited by 57
Waters, B., Saxena, G., Wanggui, Y., KAU, D. A., Wrigley, S. K., Stokes, R. W., & DAVIES, J. E. (2002) · The Journal of Antibiotics · doi:10.7164/antibiotics.55.407 · Cited by 56
Cañedo, L. M., Blanco, J. A. D. L. F., BAZ, J. P., PUENTES, J. L. F., MILLÁN, F. R., Espliego‐Vazquez, F., Fernandez‐Chimeno, R. I., & GRAVALOS, D. G. (2000) · The Journal of Antibiotics · doi:10.7164/antibiotics.53.895 · Cited by 55
Zimmermann, A., Wilts, H., Lenhardt, M., Hahn, M., & Mertens, T. (2000) · Antiviral Research · doi:10.1016/s0166-3542(00)00118-2 · Cited by 54
The safety and tolerability of a mixed lineage kinase inhibitor (CEP-1347) in PD
Parkinson Study Group (2004) · Neurology · doi:10.1212/01.wnl.0000103882.56507.20 · Cited by 54
Moreau, P., Anizon, F., Sancelme, M., Prudhomme, M., Bailly, C., Sevère, D., Riou, J., Fabbro, D., Meyer, T., & Aubertin, A.-M. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980396d · Cited by 52
Metabolism Studies of Indole Derivatives Using a Staurosporine Producer,Streptomyces staurosporeus
Yang, S., & Cordell, G. A. (1997) · Journal of Natural Products · doi:10.1021/np960566u · Cited by 51
ZHD-0501, a novel naturally occurring staurosporine analog from Actinomadura sp. 007
Xiao-xian, H., Cui, C., Gu, Q., Zhu, W., Liu, H., Gu, J., & Osada, H. (2005) · Tetrahedron Letters · doi:10.1016/j.tetlet.2005.06.154 · Cited by 51
A New Staurosporine Analog from the Prosobranch MolluskCoriocella Nigra
Cantrell, C. L., Groweiss, A., Gustafson, K. R., & Boyd, M. R. (1999) · Natural product letters · doi:10.1080/10575639908045433 · Cited by 49
Williams, D. E., Bernan, V. S., Ritacco, F. V., Maiese, W. M., Greenstein, M. D., & Andersen, R. J. (1999) · Tetrahedron Letters · doi:10.1016/s0040-4039(99)01495-1 · Cited by 49
Antimicrobial activities of indolocarbazole and bis-indole protein kinase C inhibitors.
Sancelme, M., Fabre, S., & Prudhomme, M. (1994) · The Journal of Antibiotics · doi:10.7164/antibiotics.47.792 · Cited by 48
Engineering biosynthetic pathways to generate antitumor indolocarbazole derivatives
Sánchez, C., Méndez, C., & Salas, J. A. (2006) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-006-0092-5 · Cited by 48
Self-citationActivity of Irinotecan and the Tyrosine Kinase Inhibitor CEP-751 in Medullary Thyroid Cancer
Strock, C. J., Park, J., Rosen, D. M., Ruggeri, B., Denmeade, S. R., Ball, D. W., & Nelkin, B. D. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1882 · Cited by 46
Krämer, H., Kessler, D., Hipler, U., Irlinger, B., Hort, W., Bödeker, R.-H., Steglich, W., & Mayser, P. A. (2005) · ChemBioChem · doi:10.1002/cbic.200500163 · Cited by 45
Trudell, M. L., Lifer, S. L., Tan, Y. C., Martin, M. J., Deng, L., Skolnick, P., & Cook, J. M. (1990) · Journal of Medicinal Chemistry · doi:10.1021/jm00171a015 · Cited by 45
Nakatani, S., Naoe, A., Yamamoto, Y., Yamauchi, T., Yamaguchi, N., & Ishibashi, M. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00592-4 · Cited by 44
Pityrialactone- a new fluorochrome from the tryptophan metabolism of M. alassezia furfur
Mayser, P. A., Stapelkamp, H., Krämer, H., Podobinska, M., Wallbott, W., Irlinger, B., & Steglich, W. (2003) · Antonie van Leeuwenhoek · doi:10.1023/a:1026042903354 · Cited by 43
Gaßel, M., Breitenlechner, C. B., König, N., Huber, R., Engh, R. A., & Bossemeyer, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314082200 · Cited by 43
Siderophores of the Human Pathogenic Fluorescent Pseudomonads.
Budzikiewicz, H. (2001) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026013395560 · Cited by 43
Non-camptothecin topoisomerase I active compounds as potential anticancer agents
Long, B. H., & Balasubramanian, B. N. (2000) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.10.5.635 · Cited by 43
Sánchez-Martı́nez, C., Shih, C., Zhu, G., Li, T., Brooks, H. B., Patel, B. K. R., Schultz, R. M., DeHahn, T. B., Spencer, C. D., Watkins, S. A., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00792-3 · Cited by 43
Asamizu, S., Kato, Y., Igarashi, Y., FURUMAI, T., & Onaka, H. (2005) · Tetrahedron Letters · doi:10.1016/j.tetlet.2005.11.061 · Cited by 42
Lam, K. S., Schroeder, D. R., Veitch, J. M., Colson, K. L., Matson, J. A., Rose, W. C., Doyle, T. W., & Forenza, S. (2001) · The Journal of Antibiotics · doi:10.7164/antibiotics.54.1 · Cited by 42
Predicting drug response based on gene expression
Robert, J., Vekris, A., Pourquier, P., & Bonnet, J. (2004) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(04)00111-8 · Cited by 42
Edotecarin: A Novel Topoisomerase I Inhibitor
Saif, M. W., & Diasio, R. B. (2005) · Clinical Colorectal Cancer · doi:10.3816/ccc.2005.n.014 · Cited by 39
Virchis, A. E., GANESHAGURU, K., Hart, S., Jones, D. T., Fletcher, L., Wright, F., Wickremasinghe, R. G., Man, A., Csermak, K., Meyer, T., et al. (2002) · The Hematology Journal · doi:10.1038/sj.thj.6200165 · Cited by 39
Schupp, P. J., Steube, K. G., Meyer, C., & Proksch, P. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00694-2 · Cited by 38
Undevia, S. D., Vogelzang, N. J., Mauer, A. M., Janisch, L. A., Mani, S., & Ratain, M. J. (2004) · Investigational New Drugs · doi:10.1023/b:drug.0000036687.26604.8c · Cited by 37
Drugs in development for Parkinson's disease: an update.
Johnston, T. H., & Brotchie, J. M. (2006) · PubMed · Cited by 36
Ratnakumari, L., Vysotskaya, T. N., Duch, D. S., & Hemmings, H. C. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01532-5 · Cited by 35
The evolution of cancer research and drug discovery at Lilly Research Laboratories
Pearce, H. L., & Miller, M. A. (2005) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2005.02.017 · Cited by 32
K252a and Staurosporine Microbial Alkaloid Toxins as Prototype of Neurotropic Drugs
Lazarovici, P., Rasouly, D., Friedman, L. M., Tabekman, R., Ovadia, H., & Matsuda, Y. (1996) · Advances in experimental medicine and biology · doi:10.1007/978-1-4613-0361-9_31 · Cited by 31
A new indolopyrrolocarbazole antitumor substance, ED-110, a derivative of BE-13793C.
Tanaka, S., Ohkubo, M., KOJIRI, K., Suda, H., YAMADA, A., & Uemura, D. (1992) · The Journal of Antibiotics · doi:10.7164/antibiotics.45.1797 · Cited by 29
Further Minor Metabolites of Staurosporine Produced by a Streptomyces longisporofiavus Strain.
CAI, Y., Fredenhagen, A., Hug, P., Meyer, T., & PETER, H. H. (1996) · The Journal of Antibiotics · doi:10.7164/antibiotics.49.519 · Cited by 27
Merritt, J. E., Sullivan, J. A., Drew, L., Khan, A., Wilson, K. L., Mulqueen, M. J., Harris, W. R., Bradshaw, D. J., Hill, C. H., Rumsby, M. G., et al. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050909 · Cited by 24
Gingrich, D. E., Yang, S. X., Gessner, G. W., Angeles, T. S., & Hudkins, R. L. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040178m · Cited by 23
O- andN-Methylation in the Biosynthesis of Staurosporine
Yang, S., Lin, L.-J., Cordell, G. A., Wang, P., & Corley, D. G. (1999) · Journal of Natural Products · doi:10.1021/np990261q · Cited by 21
Biosynthesis of Staurosporine: Incorporation of Glucose
Yang, S., & Cordell, G. A. (1996) · Journal of Natural Products · doi:10.1021/np960109d · Cited by 18
Yang, S., & Cordell, G. A. (1997) · Journal of Natural Products · doi:10.1021/np960674g · Cited by 16
ED‐110, a Novel Indolocarbazole, Prevents the Growth of Experimental Tumors in Mice
Arakawa, H., Iguchi, T., Yoshinari, T., KOJIRI, K., Suda, H., & Okura, A. (1993) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1993.tb00178.x · Cited by 16
Origin of Nitrogen in the Indolocarbazole Unit of Staurosporine
Yang, S., & Cordell, G. A. (1997) · Journal of Natural Products · doi:10.1021/np970192k · Cited by 15
Jeohn, G., Cooper, C. L., Jang, K., Kim, H.-C., & Hong, J. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04079.x · Cited by 14
CAI, Y., Fredenhagen, A., Hug, P., & PETER, H. H. (1996) · The Journal of Antibiotics · doi:10.7164/antibiotics.49.1060 · Cited by 13
Deuterium Labeling and Mass Fragmentation Studies of Staurosporine
Yang, S., & Cordell, G. A. (1997) · Journal of Natural Products · doi:10.1021/np960567m · Cited by 9
Cited by
Occurrence, Biogenesis, and Synthesis of Biologically Active Carbazole Alkaloids
Schmidt, A. W., Reddy, K. R., & Knölker, H.-J. (2012) · Chemical Reviews · doi:10.1021/cr200447s · Cited by 1,243
Palladium-Catalyzed Amination of Aromatic C−H Bonds with Oxime Esters
Tan, Y., & Hartwig, J. F. (2010) · Journal of the American Chemical Society · doi:10.1021/ja100676r · Cited by 551
Topoisomerases as anticancer targets
Delgado, J. L., Hsieh, C.-M., Chan, N.-L., & Hiasa, H. (2018) · Biochemical Journal · doi:10.1042/bcj20160583 · Cited by 481
A comprehensive review of glycosylated bacterial natural products
Elshahawi, S. I., Shaaban, K. A., Kharel, M. K., & Thorson, J. S. (2015) · Chemical Society Reviews · doi:10.1039/c4cs00426d · Cited by 439
Oxidative Cyclization in Natural Product Biosynthesis
Tang, M.-C., Zou, Y., Watanabe, K., Walsh, C. T., & Tang, Y. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00478 · Cited by 425
Metadata
- Authors
- Sánchez, C., Méndez, C., & Salas, J. A.
- Venue
- Nat. Prod. Rep.
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2006
- Volume
- 23
- Issue
- 6
- Pages
- 1007-1045
- ISSN
- 0265-0568 (ISSN-L)
- 1460-4752
- OpenAlex
- W2162655337
- Cited by
- 407
- References
- 153
- FWCI
- 5.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.